Stereotaxis (STXS) Operating Margin Growth (1y) (2011 - 2026)
Powered by 
Analysis
Stereotaxis (STXS) Operating Margin Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | -497.00 |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 314.00 |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 124.00 |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 670.00 |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 546.00 |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 264.00 |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | -919.00 |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 595.00 |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 146.00 |
| 10 | Stereotaxis | 129.55 Mn | 114.93 Mn | 3.79 Mn | -1,572.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -1,572.00 |
| Dec 31, 2025 | 5,493.00 |
| Sep 30, 2025 | -1,885.00 |
| Jun 30, 2025 | 8,854.00 |
| Mar 31, 2025 | -1,037.00 |
| Dec 31, 2024 | -411.00 |
| Sep 30, 2024 | 331.00 |
| Jun 30, 2024 | -6,659.00 |
| Mar 31, 2024 | 1,683.00 |
| Dec 31, 2023 | -5,516.00 |
| Sep 30, 2023 | -633.00 |
| Jun 30, 2023 | 1,704.00 |
| Mar 31, 2023 | -2,771.00 |
| Dec 31, 2022 | -2,039.00 |
| Sep 30, 2022 | -1,524.00 |
| Jun 30, 2022 | -4,672.00 |
| Mar 31, 2022 | -4,039.00 |
| Dec 31, 2021 | -2,340.00 |
| Sep 30, 2021 | -3,278.00 |
| Jun 30, 2021 | -152.00 |